Download presentation
Presentation is loading. Please wait.
Published byBennett Fleming Modified over 9 years ago
1
ClinicalTrials.gov Anna Ripple National Library of Medicine Bethesda, Maryland MLA Presentation May 2006
2
ClinicalTrials.gov Topics 1. International Committee of Medical Journal Editors (ICMJE) editorials regarding trial registration 2. Map of Locations functionality
3
Recent Headlines “Hiding the Data on Drug Trials” [NYT, 6/1/05] “Drug giants fail to name compounds in trial database” [Nature, 6/1/05] “Despite Vow, Drug Makers Still Withhold Clinical Information” [NYT, 5/31/05] “Journal editor blasts drug makers” [AP, 5/24/05] “Pfizer Reveals Study Linking Celebrex to Heart Risks” [Globe, 2/1/05]
4
Timeline FDAMA legislation passed – Nov 1997 ClinicalTrials.gov launched – April 2000 Paxil Settlement (GSK) – Aug 2004 ICMJE Statement #1 – Sept 2004 Vioxx Withdrawn (Merck) – Sept 2004 PhRMA Position Statement – Jan 2005 Fair Access to Clinical Trials (FACT) Act (S 470) – Feb 2005 WHO Advisory Group (Geneva) – Apr 2005 ICMJE Statement #2 - May 2005 IOM Working Group – June 2005 FACT Act (HR 3196) – June 2005
5
Who is the ICMJE? International Committee of Medical Journal Editors Leading medical journals including –JAMA –New England Journal of Medicine –The Lancet –Annals of Internal Medicine ICMJE editorial policies adopted by over 600 medical journals around the world
6
ICMJE Editorials International Committee of Medical Journal Editors September 2004 May 2005 Research studies must be registered in a trial registry database as a condition of publication
7
October 2004 Policy Change at ClinicalTrials.gov ClinicalTrials.gov –Meets ICMJE requirements Any trial accepted if –IRB approval –Conforms with regulations of health authority Trials may be registered by –Sponsors, principal investigators –Governmental or international agencies
8
“ClinicalTrials.gov Identifier to be added to MEDLINE/PubMed Data” (6/23/2005) (Identifier format: NCT12345678) “ClinicalTrials.gov Scope Expanded” (8/08/05)
9
ICMJE-ClinicalTrials.gov Mapping
10
ClinicalTrials.gov Demo http://clinicaltrials.gov
11
ClinicalTrials.gov Home page
12
ClinicalTrials.gov “What’s New”
13
ClinicalTrials.gov records with published results
14
PubMed citation of Trial results
15
PubMed record
16
LinkOut
18
LinkOut Display
19
ClinicalTrials.gov Record
20
LinkOut
21
ClinicalTrials.gov Record
22
PubMed Citation Format Display
23
Citation Display Format (cont’d)
24
ClinicalTrials.gov Record
25
ClinicalTrials.gov Record (cont’d)
27
Link back to PubMed citation
28
Number of Records in ClinicalTrials.gov
29
ICMJE Summary Considerable interest in trial registration ICMJE builds on FDAMA 113 –Broadens scope: more types of interventions & conditions –Introduces new use for registries –Increases incentive/awareness for registration Closer to comprehensive registration Evolution of ClinicalTrials.gov
30
2. Map of Locations functionality Click on the "Map of locations" button on the Search Results page. Locations are displayed in three ways: Map of 50 states and the District of Columbia - click on a state to display studies with locations in that state Map of the world - click on a country/region to display studies with locations there Location information for text browsers (below the maps) - click on a location name
31
ClinicalTrials.gov Search
32
Search Results
33
ClinicalTrials.gov Map of Locations
34
Map of Locations (cont’d)
36
Studies ongoing in Europe
37
Listing/Browse by Map
38
ClinicalTrials.gov List by Map
39
Studies with locations in Arizona
40
ClinicalTrials.gov Topics covered 1. International Committee of Medical Journal Editors (ICMJE) editorials regarding trial registration (icmje.org) 2. Map of Locations functionality
41
ClinicalTrials.gov http://clinicaltrials.gov Anna Ripple National Library of Medicine ripple@nlm.nih.gov MLA Presentation May 2006
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.